ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $136,000 | -99.9% | 10,694 | 0.0% | 0.07% | +9.7% |
Q1 2017 | $135,600,000 | +96070.2% | 10,694 | 0.0% | 0.06% | -29.5% |
Q3 2016 | $141,000 | +3.7% | 10,694 | 0.0% | 0.09% | +15.8% |
Q2 2016 | $136,000 | -3.5% | 10,694 | 0.0% | 0.08% | -5.0% |
Q1 2016 | $141,000 | -14.0% | 10,694 | 0.0% | 0.08% | -10.1% |
Q4 2015 | $164,000 | +23.3% | 10,694 | 0.0% | 0.09% | -5.3% |
Q3 2015 | $133,000 | -8.9% | 10,694 | 0.0% | 0.09% | +3.3% |
Q2 2015 | $146,000 | +14.1% | 10,694 | 0.0% | 0.09% | +2.2% |
Q1 2015 | $128,000 | -6.6% | 10,694 | 0.0% | 0.09% | -9.2% |
Q4 2014 | $137,000 | -65.1% | 10,694 | -63.4% | 0.10% | -69.8% |
Q3 2014 | $392,000 | +103.1% | 29,194 | +173.0% | 0.32% | +77.0% |
Q1 2014 | $193,000 | +17.0% | 10,694 | 0.0% | 0.18% | +25.3% |
Q4 2013 | $165,000 | +3.8% | 10,694 | 0.0% | 0.15% | -16.1% |
Q3 2013 | $159,000 | +15.2% | 10,694 | 0.0% | 0.17% | 0.0% |
Q2 2013 | $138,000 | – | 10,694 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |